论文部分内容阅读
本文分析了诱导化疗过程中有血小板升高反应的33例急性白血病病人的临床资料。结果发现:外周血血小板升高几乎总在白细胞和血红蛋白之前,且大部分病例可较早地先于骨髓缓解。诱导化疗中有血小板升高反应者完全缓解率78.8%,骨髓缓解率96.9%。此结果说明,血小板升高可用于预测急性白血病诱导化疗能否缓解,指导化疗方案的选择,是判断急性白血病疗效的简便指标。
This article analyzes the clinical data of 33 patients with acute leukemia induced by thrombocytopenia during chemotherapy induction. The results showed that peripheral blood thrombocytopenia almost always preceded leukocytes and hemoglobin, and most of the cases were earlier than bone marrow. Induced chemotherapy in patients with thrombocytopenia were complete response rate 78.8%, bone marrow remission rate 96.9%. This result shows that thrombocytopenia can be used to predict acute leukemia induction chemotherapy can ease, guide the choice of chemotherapy options is to determine the efficacy of acute leukemia simple indicator.